Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  54419-04 Ovarian Cancer Risk and Hypergonadotropic Hypogonadism End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
54419-04 Ovarian Cancer Risk and Hypergonadotropic Hypogonadism



  1. Sponsor Organization: NIH/NCI

  2. Project Title: 54419-04 OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISM

  3. Project Focus: HUMAN HEALTH EFFECTS

  4. Description: Experimental and epidemiologic evidence suggests human ovarian cancer is caused by hypergonadotropichypogonadism (high gonadotropins consequent to failing ovaries). To identify risk factors linked to ovarian cancer thruthis model, a population based case-control study is proposed using 650 ovarian cancer cases newly diagnosed in threeNortheast Massachusetts counties and the state of New Hampshire and using age and residence matched controlsselected via random digit dialing. Data will be obtained thru personal interview, a self- administered dietaryquestionnaire, and blood collection. Key variables possibly linked to hypogonadism and ovarian cancer are highgalactose consumption and deficient galactose metabolism. The use of galactose rich foods will be assessed andanalyzed in perspective of the subject's ability to metabolize galactose. Biochemical activity of three key enzymes willbe determined (galactokinase, galactose-1 phosphate uridyl transferase, and uridine diphosphogalactose-4- epimerase). Other exposures possibly linked to hypogonadism to be assessed include smoking, caffeine, and tannic acidconsumption. Reproductive variables, oral contraceptive (OC) use, and talc exposure will also be assessed to determinetheir interrelationship with the environmental and biochemical risk factors, particularly, whether the effect of oocytetoxins on ovarian cancer risk is more apparent among women who have never used OC's. As a secondary aim we willcreate a serum and buffy coat bank to permit a search for DNA markers possibly related to ovarian cancer includinggenetic alterations related to the locus for galactose transferase or to p53 which we speculate may indirectly relate togalactose metabolism, or via an alternate cause of hypogonadism involving chromosome deletions in the region Xq21-27. Knowledge of genetic biochemical, and environmental factors associated with ovarian cancer thruhypergonadotropic hypogonadism has public health importance in devising strategies for prevention of this disease. Therole of galactose rich foods in ovarian cancer etiology is particularly important because of a substantial increase in theuse of these foods in the United States.

  5. References:

  6. Category: MEASUREMENTS

  7. Subcategory: EXPOSURE AND RISK MODELS

  8. Keywords for Experimental System/Species: HUMAN, FIELD STUDY

  9. Keywords for Experimental Endpoints: EXPOSURE MONITORING, CARCINOGENESIS, RISK FACTORS, EPIDEMIOLGOY

  10. Chemical Agents: TANNIC ACID, ORAL CONTRACEPTIVES, OOCYTE TOXINS, CAFFEINE

  11. Performing Institution: BRIGHAM AND WOMEN'S HOSPITAL

  12. Contact: CONTACT PERSON:ELAINE C. LEE; BUILDING 31; 11A21, NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301 496-5515; LEEE@0D.NCI.NIH.GOV


 

 
Begin Site Footer